Goldman Sachs
SNNA

Goldman Sachs’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Goldman Sachs’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-52,553
Closed -$11K – 5532
2019
Q3 		$11K Buy
52,553
+6,118
+13% +$4.14K ﹤0.01% 5128
2019
Q2 		$40K Sell
46,435
-374
-0.8% -$585 ﹤0.01% 5032
2019
Q1 		$109K Buy
46,809
+30,109
+180% +$81.6K ﹤0.01% 4918
2018
Q4 		$39K Sell
16,700
-7,335
-31% -$64.7K ﹤0.01% 5113
2018
Q3 		$356K Buy
24,035
+10,102
+73% +$161K ﹤0.01% 4614
2018
Q2 		$212K Buy
13,933
+1,932
+16% +$32.8K ﹤0.01% 4972
2018
Q1 		$225K Buy
12,001
+1,259
+12% +$22K ﹤0.01% 4938
2017
Q4 		$195K Buy
+10,742
New +$227K ﹤0.01% 5441

Other funds holding SNNA

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $152B AUM 31.61% 1-Year Est. Return